by David Page, CHS National Director of Health Policy Given recent advances in therapies for inherited bleeding disorders, especially hemophilia A and B, I have...
CLICK HERE to access the November 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
CLICK HERE to access the CHS 2020 Annual Report and the complete Financial Statements.
CLICK HERE to access the June 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
The CHS is pleased to share its brand new five-year strategic framework following an extensive strategic planning exercise held in 2020. The strategy is expressed...